JAMA Oncology
Papers 1909
1 page of 191 pages (1,909 results)
#1Travis GerkeH-Index: 10
#2Shivanshu AwasthiH-Index: 1
Last.Kosj YamoahH-Index: 18
view all 3 authors...
#1Andrea Cercek (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 22
#2Thomas Boerner (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 3
Last.William R. Jarnagin (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 90
view all 31 authors...
Importance Unresectable intrahepatic cholangiocarcinoma (IHC) carries a poor prognosis, with a median overall survival (OS) of 11 months. Hepatic arterial infusion (HAI) of high-dose chemotherapy may have potential benefit in these patients. Objective To evaluate clinical outcomes when HAI chemotherapy is combined with systemic chemotherapy in patients with unresectable IHC. Design, Setting, and Participants A single-institution, phase 2 clinical trial including 38 patients was conducted with HA...
1 CitationsSource
#1Robert T. Dess (UM: University of Michigan)H-Index: 10
#2Brandon A. Mahal (Harvard University)H-Index: 18
Last.Daniel E. Spratt (UM: University of Michigan)H-Index: 29
view all 3 authors...
#1Andrea B. Apolo (NIH: National Institutes of Health)H-Index: 14
#2Matthew I. Milowsky (UNC: University of North Carolina at Chapel Hill)H-Index: 40
Last.Sundeep Agrawal (CDER: Center for Drug Evaluation and Research)
view all 25 authors...
Objective To harmonize eligibility criteria and radiographic disease assessments in clinical trials of adjuvant therapy for muscle-invasive bladder cancer (MIBC). Methods National experts in bladder cancer clinical trial research, including medical and urologic oncologists, radiologists, biostatisticians, and patient advocates, convened at a public workshop on November 28, 2017, to discuss eligibility, radiographic entry criteria, and assessment of disease recurrence in adjuvant clinical trials ...
#1Hui-Zi Gong (Peking Union Medical College Hospital)
#2Jun Li (Peking Union Medical College Hospital)
#1Julien EdelineH-Index: 19
#2Yann TouchefeuH-Index: 7
Last.Etienne GarinH-Index: 24
view all 16 authors...
Importance Patients with unresectable intrahepatic cholangiocarcinoma (ICC) have a poor prognosis. Selective internal radiotherapy (SIRT) is a promising treatment option for hepatic tumors, but no prospective studies of combination SIRT with chemotherapy have been published to our knowledge. Objective To determine the response rate after SIRT combined with chemotherapy in patients with unresectable ICC. Design, Setting, and Participants This phase 2 clinical trial, the Yttrium-90 Microspheres in...
1 CitationsSource
#1Santino Butler (Brigham and Women's Hospital)H-Index: 2
#2Karen M. WinkfieldH-Index: 9
Last.Nina N. Sanford (UTSW: University of Texas Southwestern Medical Center)H-Index: 2
view all 7 authors...
#1Zhimin Shao (Fudan University)H-Index: 21
#2Da Pang (HMU: Harbin Medical University)H-Index: 3
Last.Jennifer Eng-Wong (Genentech)H-Index: 16
view all 21 authors...
Importance Prospective assessment of treatments known to benefit patients in global clinical trials in specific racial groups is essential. Objective To compare the efficacy, safety, and tolerability of adding pertuzumab to trastuzumab and docetaxel vs placebo, trastuzumab, and docetaxel in Asian patients with ERBB2-positive early or locally advanced breast cancer. Design, Setting, and Participants This multicenter, double-blind, placebo-controlled phase 3 trial enrolled 329 women with ERBB2-pos...
Top fields of study
Breast cancer